Relay Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 05/18/2026 | 27.90 M | $277.65 M | 0.00% | 16.26% |
| COMMODORE CAPITAL LP | 05/15/2026 | 17.00 M | $169.15 M | 0.00% | 9.91% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 14.42 M | $143.46 M | 10.88% | 8.40% |
| BLACKROCK, INC. | 05/13/2026 | 12.98 M | $129.10 M | -1.91% | 7.56% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 9.75 M | $97.02 M | 412.34% | 5.68% |
| BELLEVUE GROUP AG | 05/15/2026 | 7.80 M | $77.56 M | -6.59% | 4.54% |
| 05/15/2026 | 7.39 M | $73.51 M | 100.00% | 4.31% | |
| STATE STREET CORP | 05/15/2026 | 6.23 M | $62.02 M | -3.00% | 3.63% |
| NEXTECH INVEST, LTD. | 05/15/2026 | 5.53 M | $54.99 M | 17.55% | 3.22% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 4.27 M | $42.52 M | 32.71% | 2.49% |
| FMR LLC | 05/15/2026 | 3.70 M | $36.77 M | 2,178.01% | 2.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.51 M | $34.94 M | 2.97% | 2.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 3.04 M | $30.24 M | 44.73% | 1.77% |
| 05/14/2026 | 2.98 M | $29.69 M | 0.00% | 1.74% | |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 2.94 M | $29.25 M | 18.55% | 1.71% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 2.59 M | $25.77 M | 418.00% | 1.51% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.54 M | $25.29 M | 36.69% | 1.48% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 2.36 M | $23.48 M | 5.69% | 1.38% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.94 M | $19.28 M | 86.15% | 1.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.92 M | $19.15 M | 16.99% | 1.12% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 1.90 M | $18.95 M | 100.00% | 1.11% |
| 05/08/2026 | 1.86 M | $18.54 M | 100.00% | 1.09% | |
| NORTHERN TRUST CORP | 05/14/2026 | 1.68 M | $16.67 M | 47.13% | 0.98% |
| ALPHABET INC. | 05/08/2026 | 1.56 M | $15.56 M | -0.29% | 0.91% |
| MORGAN STANLEY | 05/15/2026 | 1.43 M | $14.25 M | -29.05% | 0.83% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 1.42 M | $14.17 M | 0.00% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.37 M | $13.62 M | -12.25% | 0.80% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.29 M | $12.84 M | 10.91% | 0.75% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 1.16 M | $11.54 M | 0.00% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.11 M | $11.06 M | -2.18% | 0.65% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.06 M | $10.55 M | 111.96% | 0.62% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 05/15/2026 | 1.00 M | $9.95 M | 0.00% | 0.58% |
| MARSHALL WACE, LLP | 05/15/2026 | 941.83 K | $9.37 M | 100.00% | 0.55% |
| 05/15/2026 | 901.46 K | $8.97 M | 0.00% | 0.53% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 900.55 K | $8.96 M | 100.00% | 0.52% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 837.04 K | $8.33 M | 114.87% | 0.49% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 818.04 K | $8.14 M | 100.00% | 0.48% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 750.00 K | $7.46 M | 100.00% | 0.44% |
| WOODLINE PARTNERS LP | 05/15/2026 | 679.34 K | $6.76 M | 0.03% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 673.60 K | $6.70 M | 3.97% | 0.39% |
| INVESCO LTD. | 05/12/2026 | 669.87 K | $6.67 M | -22.60% | 0.39% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 668.29 K | $6.65 M | 100.00% | 0.39% |
| JPMORGAN CHASE & CO | 05/13/2026 | 647.52 K | $6.05 M | 52.01% | 0.38% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 619.65 K | $6.17 M | 100.00% | 0.36% |
| CONGRESS ASSET MANAGEMENT CO /MA | 04/14/2026 | 618.94 K | $6.16 M | 49.44% | 0.36% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 541.12 K | $5.38 M | 0.00% | 0.32% |
| 05/15/2026 | 536.95 K | $5.34 M | 0.00% | 0.31% | |
| UBS GROUP AG | 05/05/2026 | 527.61 K | $5.25 M | 78.24% | 0.31% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 470.54 K | $4.68 M | 100.00% | 0.27% |
| BESSEMER GROUP INC | 05/06/2026 | 457.87 K | $4.56 M | 0.00% | 0.27% |
Relay Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 281 institutional investors and hedge funds held shares of Relay Therapeutics Inc. The most heavily invested institutionals were:
SB INVESTMENT ADVISERS (UK) LTD: 27.9 M
COMMODORE CAPITAL LP: 17 M
Casdin Capital, LLC: 14.42 M
BlackRock, Inc.: 12.98 M
PERCEPTIVE ADVISORS LLC: 9.75 M
Bellevue Group AG: 7.8 M
106.73% of Relay Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 198.75 M shares in the last 24 months. This purchase volume represents approximately $2.02 B in transactions.